Page 3 - PRECONGRESS COURSE 06

CONTENTS
Course coordination, course type, course description, target audience,
educational needs and expected outcomes 05
Programme 07 Speakers’ contributions
Notes
255
Ovarian physiology: What do we need to know? 09
Nicholas Macklon (United Kingdom)
The stimulation drug FSH: What do we need to know? 19
Joop Laven (The Netherlands)
How does ovarian response effect IVF outcomes? 39
Sesh Kamal Sunkara (United Kingdom)
Ovarian response prediction in the individual patient 56
Simone Broer (The Netherlands)
Beyond FSH: which other tools matter in the stimulation phase? 81
Georgios Lainas (United Kingdom)
The day after: Luteal phase support in hyperstimulated cycles 116
Peter Humaidan (Denmark)
Individualised FSH dosing: Results of the optimist and other trials 133
Frank J. Broekmans (The Netherlands)
Management of the poor responder 152
Nikolaos P. Polyzos (Spain)
Ef cacy versus safety: Management of the high responder 173
Efstratios Kolibianakis (Greece)
Debate: Ovarian stimulation for IVF: One size ts all?
No, individualisation is mandatory 204 Christophe Blockeel (Belgium)
Yes, we need to value cost ef ciency 225
Frank J. Broekmans (The Netherlands)
Freeze all, the luteal support free solution? 242
Anja Pinborg (Denmark)
PRECONGRESS COURSE 06 I GENEVA, SWITZERLAND – 2 JULY 2017 03